Summary
This retrospective observational study examined the distribution of 21 different combinations of GLIM malnutrition criteria phenotypes and aetiologies in a cancer population, and their association with short-term clinical outcomes at 30 days. The work appears to contribute to validation of the GLIM framework as a standardised malnutrition assessment tool in oncology, exploring whether specific criterion combinations predict adverse clinical events more strongly than others. The findings may support refinement of malnutrition screening and intervention prioritisation in cancer care settings.
UK applicability
This research is directly applicable to UK oncology and nutrition practice, as GLIM is internationally adopted and cancer-related malnutrition is a significant concern in UK hospital and community settings. The 30-day outcome focus aligns with NHS quality metrics and could inform malnutrition risk stratification in UK cancer centres.
Key measures
Prevalence of GLIM malnutrition phenotypic and aetiologic criterion combinations; 30-day clinical outcomes (mortality, morbidity, complications)
Outcomes reported
The study assessed the prevalence of 21 combinations of Global Leadership Initiative on Malnutrition (GLIM) phenotypic and aetiologic criteria in people with cancer, and evaluated their association with 30-day mortality or morbidity outcomes.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.